Alabama Alaska Arizona Arkansas California Colorado Connecticut Delaware District of Columbia Florida Georgia Hawaii Idaho Illinois Indiana Iowa Kansas Kentucky Louisiana Maine Maryland Massachusetts Michigan Minnesota Mississippi Missouri Montana Nebraska Nevada New Hampshire New Jersey New Mexico New York North Carolina North Dakota Ohio Oklahoma Oregon Pennsylvania Rhode Island South Carolina South Dakota Tennessee Texas Utah Vermont Virginia Washington West Virginia Wisconsin Wyoming

About Michael Silber

This author has not yet filled in any details.
So far Michael Silber has created 2722 blog entries.

Oregon

SB 1085, legislation permitting pharmacists to test and treat for certain health conditions, requiring payment for pharmacist services and allowing pharmacists to delegate to a pharmacy technician or intern to perform testing under the pharmacist's supervision, is scheduled for a hearing in the Senate Committee on Health Care on March 29. The health conditions include influenza; lice; COVID-19 or other respiratory conditions, diseases, or illnesses; skin conditions, such as athlete's foot or ringworm; streptococcus; urinary tract infection; other health conditions identified by the Oregon Health Authority as a public health emergency or other health conditions as identified by the Board of pharmacy by rule for which a patient may be tested.  

Also in Oregon, the Board of Pharmacy is seeking subject matter experts to serve on a workgroup concerning Collaborative Drug Therapy Management (CDTMs) and Clinical Pharmacy Agreement (CPAs). The purpose of this workgroup is to gather information related to CDTMs and CPAs and provide input for rules to ensure patient health, safety and welfare. It is anticipated that the workgroup will provide input on development of updated rules and provide the Board with recommendations, insights, and input on proposed rules. See additional information below. If you would like to serve on the CDTM/CPA workgroup, please complete the online form by Friday April 7, 2023. Those that are selected will receive confirmation by Friday April 14, 2023.

For more information, contact NACDS’ Sandra Guckian at 703-774-4801.

2023-06-22T11:07:30-04:00March 24, 2023|Oregon|

South Dakota

On March 23, Gov. Kristi Noem (R) signed HB 1135, PBM legislation including requirements for PBM licensure, prohibiting retroactive fees except in certain situations and the collection of renumeration fees and adding criteria for drugs to be placed on the MAC list.

For more information, contact NACDS’ Sandra Guckian at 703-774-4801.

2023-03-24T09:54:26-04:00March 24, 2023|South Dakota|

Tennessee

TennCare has contracted with Mercer Government Human Services Consulting to conduct a professional cost of dispensing survey and a survey of acquisition cost data. Both surveys will begin on April 3 and must be submitted to Mercer no later than May 12. All network pharmacies will be required to complete the professional cost of dispensing survey; however, only select pharmacies will also be required to complete the biannual AAAC (Average Actual Acquisition Cost) survey. Please direct questions regarding the survey to Lora.Underwood@tn.gov or mercerrxpassage@mercer.com.

For more information, contact NACDS’ Leigh Knotts at 803-243-7207.

2023-03-24T09:53:43-04:00March 24, 2023|Tennessee|

Texas

To show legislators that this year pharmacies are a united front on PBM issues, NACDS submitted a support letter to the Texas House Insurance Committee on PBM ERISA reform legislation being led by the Texas Pharmacy Association and the Texas Pharmacy Business Council, HB 2021. A hearing was held on March 21.

For more information, contact NACDS’ Mary Staples at 817-442-1155.

2023-03-24T09:51:26-04:00March 24, 2023|Texas|

Alabama

Reminder, effective October 1, 2022, the Alabama Medicaid Agency removed the requirement of absence of alcohol and illicit drug use by recipients for the prior approval of antiviral drugs used in the treatment of hepatitis C. A copy of the patient's drug and alcohol screening lab report is no longer required. All other criteria remain, including the patient consent form with the patient's and physician's signature, which must be submitted with requests. 

The updated Prior Authorization (PA) request form and criteria booklet should be utilized by the prescriber or the dispensing pharmacy when requesting a PA.  

For more information, contact NACDS’ Leigh Knotts at 803-243-7207.

2023-03-10T11:13:39-05:00March 10, 2023|Alabama|

Arizona

Gov. Katie Hobbs (D) vetoed SB (Senate Bill) 1248, legislation repealing several components of the sunrise process for scope expansion, including pharmacy. 

Also in Arizona, on March 6, SB 1254 (Senate Engrossed), legislation repealing the requirement for a Schedule II opioid prescription that is directly dispensed by a pharmacist and that is not for the immediate administration to the ultimate user to have a red cap, failed to pass the House Health and Human Services Committee by a 3-4 vote.  

For more information, contact NACDS’ Sandra Guckian at 703-774-4801.

2023-03-10T11:13:10-05:00March 10, 2023|Arizona|

Arkansas

HB (House Bill) 1007, legislation establishing a statewide protocol that would allow pharmacists to diagnose and assess conditions for HIV and to dispense PrEP (Pre-Exposure Prophylaxis) and PEP (Post Exposure Prophylaxis), was amended in the House Committee on Public Health, Welfare and Labor.

For more information, contact NACDS’ Mary Staples at 817-442-1155.

2023-03-10T11:12:42-05:00March 10, 2023|Arkansas|

Colorado

SB 23-162, legislation chain pharmacies support that would increase access to pharmacy services by allowing a pharmacist to delegate to a pharmacy technician any task within the practice of pharmacy for which the pharmacy technician has been specifically trained, except for patient counseling, drug regimen review and clinical conflict resolution, was heard in the Senate Health and Human Services Committee on March 9. The bill also removes the pharmacy technician to pharmacist ratio at a central fill pharmacy, and it authorizes reimbursement under the medical assistance program for dispensing or administering vaccines to children under 19 years of age.  

Also in Colorado, HB 23-1201, a PBM reform bill that creates transparency and eliminates spread pricing, was introduced, and assigned to the House Health & Insurance Committee. 

Finally, March 15 is Pharmacy Day at the Capitol.  

For more information, contact NACDS’ Mary Staples at 817-442-1155.

2023-03-10T11:11:33-05:00March 10, 2023|Colorado|
Go to Top